-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Gastrodin is a natural product that has been isolated from a variety of marine organisms, including the sea hare (Elysia spp.
) and the sponge Polymastia boletti.
It has been found to possess a wide range of bioactivities, including cytotoxic, antiviral, and anti-inflammatory activities.
As a result, there has been significant interest in the synthesis of gastrodin and its derivatives as potential drugs.
The total synthesis of gastrodin has been achieved by several groups, with the earliest synthesis reported by R.
W.
Hoffmann and coworkers in 1974.
This synthesis involved a sequence of sixteen steps and required a quantitative yield of the target compound.
Later, more efficient synthesis routes were developed, such as the synthesis reported by T.
Suzuki and co-workers in 2003.
This synthesis involved six synthetic steps and was found to be more efficient than the earlier synthesis routes.
One of the most recent and efficient synthesis routes of gastrodin was reported by Y.
Sawamura and co-workers in 2013.
This synthesis involved a total of five synthetic steps, utilizing readily available starting materials and yielding a high yield of the target compound.
The authors also reported the absolute configuration of gastrodin, which had previously been unknown.
The synthesis of gastrodin has also been accomplished through biotechnological methods.
In 2010, C.
J.
Jett and co-workers reported the first total synthesis of gastrodin via a bioengineered strain of E.
coli.
This method involved the expression of a gastrodin biosynthetic pathway in the bacteria, which were then used to produce the target compound.
This method was found to be more efficient than chemical synthesis, and it has the potential to be scaled up for commercial production.
Gastrodin and its derivatives have shown promising bioactivities, making them attractive candidates for the development of new drugs.
However, the total synthesis of these compounds can be complex and time-consuming, which can make them difficult to produce in commercial quantities.
Therefore, there is a continued effort to develop more efficient and economical synthesis routes for these compounds.
In conclusion, the synthesis of gastrodin is a challenging task that has been extensively studied over the past several decades.
The development of more efficient and simplified synthesis routes for gastrodin is crucial for its potential use as a drug.
The recent advances in biotechnological methods for the production of gastrodin have the potential to revolutionize the production of this natural product, making it more accessible for the development of new drugs and therapies.
The development of new synthesis routes and production methods for gastrodin will have a significant impact on the pharmaceutical industry and will help to address the need for new drugs to treat a wide range of diseases.